PSNL
Personalis, Inc.
$15.79
+0.76 (+5.06%)
At close · Jul 15
Market Cap
$1.63B
Shares
104,721,098
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$69.65M
-17.7%
FY2025
Net Income
-$81.27M
0%
FY2025
Gross Margin
22.65%
-9pp
FY2025
Operating Margin
-126.43%
-45.8pp
FY2025
Diluted EPS
-$0.91
+33.6%
FY2025
Operating Cash Flow
-$74.95M
-66%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| $64.52M | $69.65M | $84.61M | $73.48M | $65.05M | $85.49M | $78.65M | $65.21M | $37.77M | $9.39M | |
| $55.66M | $53.87M | $57.79M | $55.27M | $51.7M | $53.84M | $58.53M | $43.13M | $25.97M | $11.74M | |
| $8.85M | $15.78M | $26.83M | $18.21M | $13.35M | $31.66M | $20.11M | $22.08M | $11.81M | -$2.34M | |
| — | 22.65% | 31.7% | 24.78% | 20.52% | 37.03% | 25.57% | 33.86% | 31.25% | -24.94% | |
| $52.16M | $50.26M | $48.91M | $64.78M | $64.91M | $49.31M | $28.57M | $22.42M | $14.3M | $9.92M | |
| $59.21M | $53.57M | $46.19M | $49.73M | $63.97M | $47.7M | $33.69M | $22.08M | $11.27M | $9.9M | |
| $9.83M | $10.05M | $10.94M | $11.3M | $8.43M | $6.01M | $5.76M | $4.75M | $3.07M | $1.22M | |
| — | — | — | $8.08M | — | — | — | — | — | — | |
| $167.04M | $157.71M | $152.88M | $183.42M | $180.58M | $150.85M | $120.79M | $87.63M | $51.54M | $31.56M | |
| -$102.52M | -$88.06M | -$68.27M | -$109.94M | -$115.53M | -$65.35M | -$42.15M | -$22.42M | -$13.77M | -$22.16M | |
| — | -126.43% | -80.68% | -149.61% | -177.61% | -76.44% | -53.59% | -34.38% | -36.45% | -235.95% | |
| -$92.69M | -$78.01M | -$57.33M | -$98.64M | -$107.1M | -$59.34M | -$36.39M | -$17.67M | -$10.7M | -$20.95M | |
| $224K | $205K | $24K | $110K | $201K | $184K | $2000 | $1.13M | $1.89M | $1.3M | |
| $7.3M | $7.16M | $5.51M | $5.9M | $2.4M | $367K | $949K | $1.62M | $293K | $100K | |
| -$76K | -$142K | -$18.49M | -$4.07M | $61K | -$42K | -$24K | -$1.44M | $150K | -$227K | |
| -$95.52M | -$81.25M | -$81.27M | -$108.21M | -$113.28M | -$65.21M | -$41.22M | -$25.08M | -$19.88M | -$23.59M | |
| $30K | $21K | $18K | $83K | $40K | $14K | $57K | $9000 | $7000 | $5000 | |
| -$95.55M | -$81.27M | -$81.28M | -$108.3M | -$113.32M | -$65.23M | -$41.28M | -$25.08M | -$19.89M | -$23.6M | |
| — | -116.69% | -96.06% | -147.38% | -174.2% | -76.29% | -52.49% | -38.47% | -52.64% | -251.23% | |
| — | — | — | — | — | — | -$41.28M | -$25.08M | -$19.89M | -$23.6M | |
| -$95.6M | -$81.14M | -$81.09M | -$107.61M | -$114.06M | -$65.41M | -$41.25M | -$25.08M | -$19.89M | -$23.59M | |
| USD/shares | — | -$0.91 | -$1.37 | -$2.25 | -$2.48 | -$1.49 | -$1.20 | — | — | — |
| USD/shares | — | -$0.91 | -$1.37 | -$2.25 | -$2.48 | -$1.49 | -$1.20 | — | — | — |
| shares | — | 89.24M | 59.25M | 48.18M | 45.7M | 43.89M | 34.37M | 18.01M | 3.06M | 3.04M |
| shares | — | 89.24M | 59.25M | 48.18M | 45.7M | 43.89M | 34.37M | 18.01M | 3.06M | 3.03M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Diagnostics & Research median 2.95×
EV/EBIT
—
Diagnostics & Research median 31.75×
P/E (TTM)
—
Diagnostics & Research median 32.60×